Emmaus Life Sciences (EMMA) Share-based Compensation (2010 - 2026)
Emmaus Life Sciences (EMMA) posted Share-based Compensation of $1,000 for Q1 2026, down 90.0% from $10,000 a year earlier and down 85.7% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Share-based Compensation (2010 - 2026) Analysis & Trends
For FY2025, Emmaus Life Sciences' Share-based Compensation came in at $25,000, down 90.2% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of -49.2% (FY2020 to FY2025).
- In prior years, Emmaus Life Sciences' Share-based Compensation was $256,000 in FY2024 (-79.7%), $1.26 million in FY2023 (+960.5%), $119,000 in FY2022 (-78.5%) and $553,000 in FY2021 (-25.2%).
- Quarterly Share-based Compensation has run from a low of -$1,000 in Q2 2025 to a high of $1.2 million in Q1 2023 over five years.
- On a year-over-year basis, Share-based Compensation has declined in each of the last three quarters, with an average decline of 27.4% over the last seven quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q2 2023, with growth of 200.0%; the weakest was Q1 2022, with a decline of 99.0%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $7,000 (Q4 2025), $9,000 (Q3 2025) and -$1,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 9,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 29,000.00 |
| Sep 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 29,000.00 |
| Mar 31, 2024 | 170,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | 64,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Mar 31, 2021 | 500,000.00 |
API Access
Emmaus Life Sciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();